Journal Home
Search for

Volume 38, Issue 6, Pages 837-848 (December 2009)


View previous. 6 of 17 View next.

Frequency and Self-Management of Pain, Dyspnea, and Cough in Cystic Fibrosis

Simone J. Stenekes, RN, MNaCorresponding Author Informationemail address, Amy Hughes, BSc, MDb, Marie-Claude Grégoire, MD, MSc, FRCPCcf, Gerri Frager, RN, MD, FRCPCd, Walter M. Robinson, MD, MPHd, Patrick J. McGrath, OC, PhD, FRSCcdeg

Accepted 6 April 2009. published online 12 October 2009.

Abstract 

Cystic fibrosis (CF) has been transformed from a fatal diagnosis in infancy to a chronic disease of children and young adults. Symptom patterns and disease burden in CF may be shifting to reflect the relatively healthier, older population with the disease. Self-management of symptoms is a hallmark of chronic illness, and yet we do not have a good understanding of how CF patients monitor or manage their symptoms. Children and adults were recruited through clinics in three Canadian provinces. Questionnaires with open-ended and close-ended questions in English and French, designed to assess the frequency, severity, and self-management of pain, breathlessness, and cough, were mailed to all the eligible participants. One hundred twenty-three respondents completed the survey, for a response rate of 64%. Eighty-four percent (103 of 123) of participants reported having pain. They reported an average of 2.1 locations of pain, with headache and abdominal pain most frequently described. Sixty-four percent (76 of 123) of participants reported having breathlessness, and 83% (99 of 123) of participants reported experiencing cough. Sixty-three percent (62 of 99) of participants with cough reported that cough always or sometimes interfered with their sleep. A variety of pharmacological and nonpharmacological treatments were used to manage symptoms. Pain and dyspnea are more common than suspected and a wide variety of pharmacological and nonpharmacological measures are used to treat symptoms. Cough is difficult to assess, but disturbed sleep may be an indicator of cough severity and an important symptom to consider when evaluating the overall burden of illness in those with CF.

a Palliative Care Program, Winnipeg Regional Health Authority and Canadian Virtual Hospice, Winnipeg, Manitoba, Canada

b Dalhousie University Medical School, IWK Health Centre, Halifax, Nova Scotia, Canada

c Centre for Pediatric Pain Research, IWK Health Centre, Halifax, Nova Scotia, Canada

d Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada

e Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada

f Department of Anesthesia, Dalhousie University, Halifax, Nova Scotia, Canada

g IWK Health Centre, Halifax, Nova Scotia, Canada

Corresponding Author InformationAddress correspondence to: Simone J. Stenekes, RN, MN, Winnipeg Regional Health Authority, Palliative Care Program, A9024-409 Tache Avenue, Winnipeg, Manitoba R2H 2A6, Canada.

 Financial assistance for the research was provided by the Nova Scotia Lung Association, with additional support from an IWK Health Centre Summer Research Studentship, which had matching funds contributed by the IWK Pediatric Palliative Care Program. These funding sources had no role in study design, data collection, analysis, interpretation of results, in writing the report, or in the decision to submit the article for publication. The corresponding author had full access to all the data and had final responsibility for the decision to submit for publication.

 S.J.S., A.H., G.F., and W.M.R. have no conflict of interest. M.-C.G. is supported by an IWK Board of Directors and a CIHR Fellowship, and has no conflict of interest. P.J.M. is supported by a Canada Research Chair and has no conflict of interest.

PII: S0885-3924(09)00747-7

doi:10.1016/j.jpainsymman.2009.04.029


View previous. 6 of 17 View next.